29 research outputs found
Improvement of nutrient absorption may enhance systemic oxidative stress in cystic fibrosis patients.
BACKGROUND: The life expectancy of patients with cystic fibrosis (CF) is largely dependent on the pulmonary disease severity and progress. Malnutrition may be an important complicating factor in active and chronic lung disease. AIMS: The focus of this study was to investigate several inflammatory markers in pancreatic-insufficient CF patients with different enzyme treatment regimens. METHODS: CF patients with pancreatic insufficiency were examined at a time of symptomatic exacerbation of their lung disease. Group A (n = 11) regularly received microspheric enzymes. Group B (n = 8) were treated with enzymes during the hospitalization period only and demonstrated the presence of malnutrition. Inflammatory markers in the sputa (neutrophil elastase activity, interleukin-8 and tumour necrosis factor-alpha levels) and in the peripheral blood (plasma malondialdehyde (MDA), lymphocyte response to PHA, and the cell sensitivity to steroid suppression) have been investigated. RESULTS: During acute lung exacerbation, group B demonstrated reduced levels of lymphocyte proliferation. This parameter was normalized after combined antibiotic and pancreatic enzyme therapy. Simultaneously, plasma MDA in group B markedly increased following treatment. For this group, a significant positive linear association between values of plasma MDA and lymphocyte proliferation has been observed. For group A, neither the same correlation nor changes in MDA levels and lymphocyte proliferation have been found. CONCLUSIONS: Our data indicate that acute lung exacerbation in malnourished CF patients may be associated with alteration in T-lymphocyte activity. Adequate therapy normalizes lymphocyte function but results in systemic oxidative stress
Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mortality in cystic fibrosis (CF), an autosomal recessive genetic disorder associated with improper function of chloride channels. Inflammation in CF lung is greatly amplified after Pseudomonas aeruginosa infection. In this study the relationship between P. aeruginosa status and inflammatory markers has been investigated. Seventeen CF children in acute lung exacerbation were examined. CF patients without P. aeruginosa infection were characterized by elevated activity of sputum elastase, reduced response of peripheral blood lymphocytes to PHA and significant resistance to the antiproliferative action of glucocorticoids. These parameters were normalized after antibiotic treatment. The patients with prolonged P. aeruginosa infection demonstrated extremely high levels of elastase activity and elevated amounts of sputum IL-8 and TNF-alpha. Although antibiotic treatment resulted in clinical improvement, it failed to suppress excessive immune response in the lung. The data indicate that CF patients with prolonged P. aeruginosa need the modified treatment, which should include immunomodulating drugs and protease inhibitors as well as antibacterial therapy
ΠΠ°ΡΠΊΠ΅ΡΡ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΌΡΠΊΠΎΠ²ΠΈΡΡΠΈΠ΄ΠΎΠ·ΠΎΠΌ
Inflammatory markers dynamics in 75 cystic fibrosis (CF) patients during a treatment of lung disease exacerbation has been investigated. As a rule, a clinical improvement is associated with decrease in the tumor necrosis factor-alpha and interleukin-8 levels in the sputum specimens. The neutrophil elastase (NE) activity assay is of special interest. It is the single inflammatory marker, which reflects the disease severity. Thus, CF patients with relatively good lung function (FVC and FEV1>70%) demonstrated lower NE activity. In contrast, the subjects with poor lung function (FVC and FEV1<70%) show the higher NE activity in the sputa. Though successful antibacterial therapy usually resulted in a decrease in the sputum elastase activity some severe CF patients demonstrate its elevation. This paradoxical result may be associated with neutrophil death and NE deliberation in the CF lung. It is very difficult to find the signs of systemic inflammation in peripheral blood of CF patients. However, our experience shows that the change of the peripheral blood lymphocytes sensitivity to the corticosteroid (dexamethasone) antiproliferative effect can inform a physician about the inflammatory process activation and an antibacterial treatment efficacy. Malon dialdehyde (MDA) plasma concentration is another parameter, which can show paradoxical results in CF subjects. During acute lung exacerbation some patients who were treated with enzymes during hospitalization period only in spite of the pancreatic insufficiency demonstrated marked increase in plasma MDA level. Authors postulate that such the increase does not reflect the activation of the infection but resuits from the systemic oxidative stress. The latter is a consequence of the improvement in fat absorption and of increase in the number of free radical targets.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠΈ ΠΌΠ°ΡΠΊΠ΅ΡΠΎΠ² Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Ρ 75 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΌΡΠΊΠΎΠ²ΠΈΡΡΠΈΠ΄ΠΎΠ·ΠΎΠΌ (MB) ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΎ, ΡΡΠΎ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅, ΠΊΠ°ΠΊ ΠΏΡΠ°Π²ΠΈΠ»ΠΎ, ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π»ΠΎΡΡ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ΠΌ Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ ΡΠ°ΠΊΡΠΎΡΠ° Π½Π΅ΠΊΡΠΎΠ·Π° ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ-Π° ΠΈ ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π°-8. ΠΡΠΎΠ±ΡΠΉ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΠ΅Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π½Π΅ΠΉΡΡΠΎΡΠΈΠ»ΡΠ½ΠΎΠΉ ΡΠ»Π°ΡΡΠ°Π·Ρ (ΠΠ), ΠΏΠΎΡΠΊΠΎΠ»ΡΠΊΡ ΡΡΠΎ Π΅Π΄ΠΈΠ½ΡΡΠ²Π΅Π½Π½ΡΠΉ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ, ΠΎΡΡΠ°ΠΆΠ°ΡΡΠΈΠΉ ΡΡΠΆΠ΅ΡΡΡ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ. Π’Π°ΠΊ, Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠΎΡ
ΡΠ°Π½Π½ΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠ΅ΠΉ Π»Π΅Π³ΠΊΠΈΡ
(Π€ΠΠΠ ΠΈ ΠΠ€Π1>70%) ΠΎΠ±Π½Π°ΡΡΠΆΠΈΠ²Π°Π»Π°ΡΡ ΠΈ Π±ΠΎΠ»Π΅Π΅ Π½ΠΈΠ·ΠΊΠ°Ρ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠ»Π°ΡΡΠ°Π·Ρ Π² ΠΌΠΎΠΊΡΠΎΡΠ΅. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Ρ
ΡΠ΄ΡΠΈΠΌΠΈ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΡΠΌΠΈ Π²Π½Π΅ΡΠ½Π΅Π³ΠΎ Π΄ΡΡ
Π°Π½ΠΈΡ (Π€ΠΠΠ ΠΈ ΠΠ€Π1<70%) Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΡΠ»Π°ΡΡΠ°Π·Ρ Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ Π±ΡΠ»Π° Π²ΡΡΠ΅. Π₯ΠΎΡΡ ΡΡΠΏΠ΅ΡΠ½Π°Ρ Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ ΠΎΠ±ΡΡΠ½ΠΎ ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΠ»Π° ΠΊ Π·Π°ΠΌΠ΅ΡΠ½ΠΎΠΌΡ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΠ, Ρ Π½Π΅ΠΊΠΎΡΠΎΡΡΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ ΡΡΠΆΠ΅Π»ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ MB Π΄Π°Π½Π½ΡΠΉ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ ΠΏΠΎΠ²ΡΡΠ°Π»ΡΡ. ΠΡΠΎΡ ΠΏΠ°ΡΠ°Π΄ΠΎΠΊΡΠ°Π»ΡΠ½ΡΠΉ ΡΠ΅Π·ΡΠ»ΡΡΠ°Ρ ΠΌΠΎΠΆΠ΅Ρ Π±ΡΡΡ ΡΠ²ΡΠ·Π°Π½ Ρ ΠΌΠ°ΡΡΠΎΠ²ΠΎΠΉ Π³ΠΈΠ±Π΅Π»ΡΡ Π½Π΅ΠΉΡΡΡΡΠΈΠ»ΠΎΠ² Π² Π»Π΅Π³ΠΊΠΈΡ
ΠΈ ΠΎΡΠ²ΠΎΠ±ΠΎΠΆΠ΄Π΅Π½ΠΈΠ΅ΠΌ ΠΠ. ΠΠ΅ΡΠΌΠΎΡΡΡ Π½Π° ΡΠΎ ΡΡΠΎ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
MB Π² ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΡΡΡΠ΄Π½ΠΎ ΠΎΠ±Π½Π°ΡΡΠΆΠΈΡΡ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ, ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ² ΠΊ Π°Π½ΡΠΈΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠΌΡ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ Π΄Π΅ΠΊΡΠ°ΠΌΠ΅ΡΠ°Π·ΠΎΠ½Π° ΠΌΠΎΠΆΠ΅Ρ Π΄Π°ΡΡ ΠΎΠ±ΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡ ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΠΈ ΠΎΡΠ°Π³Π° Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. ΠΡΠ΅ ΠΎΠ΄Π½ΠΈΠΌ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΎΠΌ, ΠΈΠ·ΠΌΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΡΠΎΡΠΎΠ³ΠΎ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠ ΠΌΠΎΠΆΠ΅Ρ Π΄Π°Π²Π°ΡΡ ΠΏΠ°ΡΠ°Π΄ΠΎΠΊΡΠ°Π»ΡΠ½ΡΠ΅ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΡ, ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΡΠΎΠ²Π΅Π½Ρ ΠΌΠ°Π»ΠΎΠ½ΠΎΠ²ΠΎΠ³ΠΎ Π΄ΠΈΠ°Π»ΡΠ΄Π΅Π³ΠΈΠ΄Π° (ΠΠΠ) Π² ΠΏΠ»Π°Π·ΠΌΠ΅. Π£ Π³ΡΡΠΏΠΏΡ Π±ΠΎΠ»ΡΠ½ΡΡ
Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΎΡΡ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ ΠΠΠ Π½Π° ΡΠΎΠ½Π΅ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. ΠΠΎΠ»ΡΠ½ΡΠ΅ ΡΡΠΎΠΉ Π³ΡΡΠΏΠΏΡ, Π½Π΅ΡΠΌΠΎΡΡΡ Π½Π° Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΡ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΠΎΡΡΡ ΡΠΊΡΠΊΡΠ΅ΡΠΎΡΠ½ΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΏΠΎΠ΄ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠ½ΠΎΠΉ ΠΆΠ΅Π»Π΅Π·Ρ, Π½Π°ΡΠΈΠ½Π°Π»ΠΈ ΠΏΠΎΠ»ΡΡΠ°ΡΡ Π·Π°ΠΌΠ΅ΡΡΠΈΡΠ΅Π»ΡΠ½ΡΡ ΡΠ΅ΡΠ°ΠΏΠΈΡ ΡΠΎΠ»ΡΠΊΠΎ Π² ΡΡΠ°ΡΠΈΠΎΠ½Π°ΡΠ΅. ΠΠ²ΡΠΎΡΡ ΠΏΠΎΠ»Π°Π³Π°ΡΡ, ΡΡΠΎ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ ΡΡΠΎΠ²Π½Ρ ΠΠΠ Π½Π΅ ΡΠ²ΡΠ·Π°Π½ΠΎ Β Ρ ΠΎΠ±ΠΎΡΡΡΠ΅Π½ΠΈΠ΅ΠΌ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ°, Π° ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΎΠΊΡΠΈΠ΄Π°ΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΡΡΠ΅ΡΡΠ°, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΡΠ»ΡΡΡΠ΅Π½ΠΈΠ΅ Π²ΡΠ°ΡΡΠ²Π°Π½ΠΈΡ ΠΆΠΈΡΠΎΠ², ΡΠ²ΡΠ·Π°Π½Π½ΠΎΠ΅ Ρ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΠ΅ΠΌ ΡΠ΅ΡΠΌΠ΅Π½ΡΠΎΠ², Π²Π΅Π΄Π΅Ρ ΠΊ ΡΠ΅Π·ΠΊΠΎΠΌΡ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ ΡΠΈΡΠ»Π° ΠΌΠΈΡΠ΅Π½Π΅ΠΉ Π΄Π»Ρ ΡΠ²ΠΎΠ±ΠΎΠ΄Π½ΡΡ
ΡΠ°Π΄ΠΈΠΊΠ°Π»ΠΎΠ²
ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π½ΠΈΠΌΠ΅ΡΡΠ»ΠΈΠ΄Π° Π² Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ ΠΌΡΠΊΠΎΠ²ΠΈΡΡΠΈΠ΄ΠΎΠ·ΠΎΠΌ
The purpose of our study was to examine the antiinflammatory effect of nimesulide the novel selective cyclooxygenase-2 inhibitor. Fifteen CF patients (the mean age 11.9 years) were treated with basic therapy and nimesulide in the daily dose of 3 mg per kg of the body weight. Inflammatory markers in the sputum samples (neutrophil elastase activity, TNF-Ξ± and IL-8 concentrations) and in peripheral blood (sensitivity of lymphocytes to antiproliferative effect of glucocorticoids and plasma TNF-Ξ± level) have been determined. During the six-month period before the start of Nimesulide, most patients had experienced a decline in FEV1 and FVC. Following the nimesulide treatment the lung disease progression became slower. The patients with poor lung function showed an essential elevation of neutrophil elastase activity and decrease of TNF-Ξ± in their sputa. Authors postulate that elastase activity elevation is associated with the destruction of neutrophils following the antiinflammatory treatment. Decrease in plasma concentrations of TNF-Ξ± as well as in the number of activated lymphocytes in peripheral blood is an evidence of the systemic antiinflammatory effect of nimesulide.ΠΡΠΊΠΎΠ²ΠΈΡΡΠΈΠ΄ΠΎΠ· (MB) β ΡΡΠΆΠ΅Π»ΠΎΠ΅ Π°ΡΡΠΎΡΠΎΠΌΠ½ΠΎ-ΡΠ΅ΡΠ΅ΡΡΠΈΠ²Π½ΠΎΠ΅ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎΠ΅ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΡΡΡΠ΅Π΅ΡΡ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΠ²Π½ΡΠΌ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ΠΌ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π±ΡΠΎΠ½Ρ
ΠΎΠ»Π΅Π³ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° Ρ ΡΠ°ΡΡΡΠΌΠΈ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²Π°ΠΌΠΈ ΡΠ΅ΡΠΏΠΈΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ. Π£ ΠΌΠ½ΠΎΠ³ΠΈΡ
Π±ΠΎΠ»ΡΠ½ΡΡ
MB Ρ ΠΏΡΠΈΡΠΎΠ΅Π΄ΠΈΠ½ΠΈΠ²ΡΠ΅ΠΉΡΡ ΠΎΠΏΠΏΠΎΡΡΡΠ½ΠΈΡΡΠΈΡΠ΅ΡΠΊΠΎΠΉ (ΠΎΠ±ΡΡΠ½ΠΎ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΠ½Π΅Π³Π½ΠΎΠΉΠ½ΠΎΠΉ) ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ ΠΎΡΠΌΠ΅ΡΠ°Π΅ΡΡΡ Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠΉ, Π½ΠΎ ΠΌΠ°Π»ΠΎΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΉ ΠΈΠΌΠΌΡΠ½Π½ΡΠΉ ΠΎΡΠ²Π΅Ρ, ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°ΡΡΠΈΠΉΡΡ ΠΈΠ½ΡΠ΅Π½ΡΠΈΠ²Π½ΠΎΠΉ ΠΌΠΈΠ³ΡΠ°ΡΠΈΠ΅ΠΉ ΠΊΠ»Π΅ΡΠΎΠΊ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ Π² Π»Π΅Π³ΠΊΠΈΠ΅.Π¦Π΅Π»ΡΡ Π½Π°ΡΡΠΎΡΡΠ΅ΠΉ ΡΠ°Π±ΠΎΡΡ Π±ΡΠ»ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
MB ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ Π½ΠΈΠΌΠ΅ΡΡΠ»ΠΈΠ΄Π° β Π½ΠΎΠ²ΠΎΠ³ΠΎ ΡΠ΅Π»Π΅ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠ° ΡΠΈΠΊΠ»ΠΎΠΎΠΊΡΠΈΠ³Π΅Π½Π°Π·Ρ-2. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π±ΡΠ»ΠΎ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ Ρ 15 Π±ΠΎΠ»ΡΠ½ΡΡ
MB (ΡΡΠ΅Π΄Π½ΠΈΠΉ Π²ΠΎΠ·ΡΠ°ΡΡ 11,9 Π³ΠΎΠ΄Π°). Π£ 9 Π±ΠΎΠ»ΡΠ½ΡΡ
(Π³ΡΡΠΏΠΏΠ° Π) ΠΎΡΠΌΠ΅ΡΠ΅Π½Ρ ΡΡΠΆΠ΅Π»ΠΎΠ΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π±ΡΠΎΠ½Ρ
ΠΎΠ»Π΅Π³ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° Π½Π° ΡΠΎΠ½Π΅ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΈΠ½Π΅Π³Π½ΠΎΠΉΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΈ Π½ΠΈΠ·ΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΡΠ½ΠΊΡΠΈΠΈ Π²Π½Π΅ΡΠ½Π΅Π³ΠΎ Π΄ΡΡ
Π°Π½ΠΈΡ (Π€ΠΠ). Π£ 6 Π±ΠΎΠ»ΡΠ½ΡΡ
(Π³ΡΡΠΏΠΏΠ° Π) Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΡΠ΅ΠΊΠ°Π»ΠΎ Π±ΠΎΠ»Π΅Π΅ Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎ ΠΈ ΡΡΠ½ΠΊΡΠΈΡ Π»Π΅Π³ΠΊΠΈΡ
Π±ΡΠ»Π° ΠΎΡΠ½ΠΎΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠΎΡ
ΡΠ°Π½Π½Π°. ΠΠΎΠΌΠΈΠΌΠΎ ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ½ΡΡΠΎΠΉ Π±Π°Π·ΠΈΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, Π±ΠΎΠ»ΡΠ½ΡΠ΅ Π΅ΠΆΠ΅Π΄Π½Π΅Π²Π½ΠΎ Π² 2 ΠΏΡΠΈΠ΅ΠΌΠ° ΠΏΠΎΠ»ΡΡΠ°Π»ΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°Ρ Π½ΠΈΠΌΠ΅ΡΡΠ»ΠΈΠ΄ Π² ΡΡΡΠΎΡΠ½ΠΎΠΉ Π΄ΠΎΠ·Π΅ 3 ΠΌΠ³ Π½Π° 1 ΠΊΠ³ ΠΌΠ°ΡΡΡ ΡΠ΅Π»Π°. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Π΄ΠΎ ΠΈ ΡΠ΅ΡΠ΅Π· 3 ΠΈ 6 ΠΌΠ΅Ρ ΠΏΠΎΡΠ»Π΅ Π½Π°ΡΠ°Π»Π° Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ ΠΌΠ°ΡΠΊΠ΅ΡΡ Π²ΠΎΡΠΏΠ°Π»Π΅Π½ΠΈΡ. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ Π² ΠΌΠΎΠΊΡΠΎΡΠ΅ (ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ ΡΠ°ΠΊΡΠΎΡΠ° Π½Π΅ΠΊΡΠΎΠ·Π° ΠΎΠΏΡΡ
ΠΎΠ»Π΅ΠΉ Ξ± (Π€ΠΠΞ±), ΠΈΠ½ΡΠ΅ΡΠ»Π΅ΠΉΠΊΠΈΠ½Π°-8 (ΠΠ-8), Π° ΡΠ°ΠΊΠΆΠ΅ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π½Π΅ΠΉΡΡΠΎΡΠΈΠ»ΡΠ½ΠΎΠΉ ΡΠ»Π°ΡΡΠ°Π·Ρ) ΠΈ ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ (ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ² ΠΊ Π°Π½ΡΠΈΠΏΡΠΎΠ»ΠΈΡΠ΅ΡΠ°ΡΠΈΠ²Π½ΠΎΠΌΡ Π΄Π΅ΠΉΡΡΠ²ΠΈΡ Π³Π»ΡΠΊΠΎΠΊΠΎΡΡΠΈΠΊΠΎΠΈΠ΄ΠΎΠ² ΠΈ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π€ΠΠΞ±). Π ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠ»ΡΠ³ΠΎΠ΄ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄Π°, ΠΏΡΠ΅Π΄ΡΠ΅ΡΡΠ²ΠΎΠ²Π°Π²ΡΠ΅Π³ΠΎ Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈΡ Π½ΠΈΠΌΠ΅ΡΡΠ»ΠΈΠ΄Π°, Ρ Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π½Π°Π±Π»ΡΠ΄Π°Π»ΠΎΡΡ ΡΡΡΠΎΠΉΡΠΈΠ²ΠΎΠ΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ Π²Π½Π΅ΡΠ½Π΅Π³ΠΎ Π΄ΡΡ
Π°Π½ΠΈΡ (ΠΠ€Π1 ΠΈ Π€ΠΠΠ). Π Π΅Π³ΡΠ»ΡΡΠ½ΡΠΉ ΠΏΡΠΈΠ΅ΠΌ Π½ΠΈΠΌΠ΅ΡΡΠ»ΠΈΠ΄Π° Π±ΠΎΠ»ΡΠ½ΡΠΌΠΈ MB ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π»ΠΎΡΡ Π·Π°ΠΌΠ΅Π΄Π»Π΅Π½ΠΈΠ΅ΠΌ ΠΏΡΠΎΠ³ΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π±ΡΠΎΠ½Ρ
ΠΎΠ»Π΅Π³ΠΎΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠ΅ΡΡΠ° ΠΈ ΡΡΠ°Π±ΠΈΠ»ΠΈΠ·Π°ΡΠΈΠ΅ΠΉ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π€ΠΠ. Π£ Π±ΠΎΠ»ΡΠ½ΡΡ
Π³ΡΡΠΏΠΏΡ Π ΡΠ΅ΡΠ°ΠΏΠΈΡ Π½ΠΈΠΌΠ΅ΡΡΠ»ΠΈΠ΄ΠΎΠΌ ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°Π»Π°ΡΡ Π·Π°ΠΌΠ΅ΡΠ½ΡΠΌ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ΠΌ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ»Π°ΡΡΠ°Π·Ρ Π² ΠΌΠΎΠΊΡΠΎΡΠ΅, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠ½ΠΈΠΆΠ΅Π½ΠΈΠ΅ΠΌ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ Π€ΠΠΞ±. ΠΠ²ΡΠΎΡΡ ΠΏΠΎΠ»Π°Π³Π°ΡΡ, ΡΡΠΎ Π½Π°Π±Π»ΡΠ΄Π°Π΅ΠΌΠΎΠ΅ ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΡΠ»Π°ΡΡΠ°Π·Ρ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ»Π΅Π΄ΡΡΠ²ΠΈΠ΅ΠΌ Π΄Π΅ΡΡΡΡΠΊΡΠΈΠΈ Π½Π΅ΠΉΡΡΠΎΡΠΈΠ»ΠΎΠ² Π½Π° ΡΠΎΠ½Π΅ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ. Π‘Π½ΠΈΠΆΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ½ΡΠ΅Π½ΡΡΠ°ΡΠΈΠΈ Π€ΠΠΞ± Π² ΠΏΠ»Π°Π·ΠΌΠ΅, Π° ΡΠ°ΠΊΠΆΠ΅ ΡΠΌΠ΅Π½ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π° Π°ΠΊΡΠΈΠ²ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π»ΠΈΠΌΡΠΎΡΠΈΡΠΎΠ² Π² ΠΏΠ΅ΡΠΈΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΡΠΎΠ²ΠΈ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΡΡ ΠΎ Π½Π°Π»ΠΈΡΠΈΠΈ ΡΠΈΡΡΠ΅ΠΌΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΡΠΈΠ²ΠΎΠ²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΡΡΡΠ΅ΠΊΡΠ° Π½ΠΈΠΌΠ΅ΡΡΠ»ΠΈΠ΄Π°
ΠΠ½Π³Π°Π»ΡΡΠΈΠΈ ΡΠ»ΡΡΡΠ°ΠΌΠ°Π»ΡΡ Π΄ΠΎΠ· Π°Π»ΠΊΠΈΠ»ΠΈΡΡΡΡΠΈΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ² Π² Π»Π΅ΡΠ΅Π½ΠΈΠΈ Π±ΡΠΎΠ½Ρ ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ
The treatment of severe steroid-dependent asthma is a very serious problem. Our aim was to work out a new method of asthma treatment with inhalations of ultra-low (non-cytotoxic) doses of an alkylating drug (Melphalan) and to investigate its efficacy and tolerability.Forty-two patients with moderate and severe asthma, enrolled into a randomized, double-blind, placebo-controlled trial, were divided into two groups: 21 patients from the Melphalan-treated group (MTG) were treated with the standard therapy plus 5 daily inhalations of 0.1 mg of Melphalan, while the control group (CG) patients (21 persons) were treated with the standard therapy plus placebo inhalations. Spirometric, biochemical, hematological and immunological data were obtained before and 10 days after the treatment. Fiberoptic bronchoscopy with further investigation of bronchial mucosa biopsies was performed in 33 of 42 patients. There were no adverse events during the study. No patient dropped out of this study. An exertion tolerance increased and exacerbation severity and frequency of p2-agonist inhalations markedly reduced in MTG. A positive dynamics of lung ventilation parameters (p<0.05) and of the exertion tolerance was revealed in MTG, while changes in the CG were unreliable. In 60% of MTG patients histo-ultrastructural signs of bronchial epithelium regeneration were revealed.In conclusion, our data suggest that combined therapy with inhalation of ultra-low doses of Melphalan is a safe and effective method of asthma treatment and needs further investigations.ΠΠ΅ΡΠ΅Π½ΠΈΠ΅ ΡΡΠΆΠ΅Π»ΠΎΠΉ Π±ΡΠΎΠ½Ρ
ΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π°ΡΡΠΌΡ (ΠΠ) Π² Π½Π°ΡΡΠΎΡΡΠ΅Π΅ Π²ΡΠ΅ΠΌΡ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ΅ΡΡΠ΅Π·Π½ΠΎΠΉ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΎΠΉ. Π¦Π΅Π»ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠ° Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΠ ΡΠ»ΡΡΡΠ°Π½ΠΈΠ·ΠΊΠΈΠΌΠΈ (Π½Π΅ ΡΠΈΡΠΎΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ) Π΄ΠΎΠ·Π°ΠΌΠΈ Π°Π»ΠΊΠΈΠ»ΠΈΡΡΡΡΠ΅Π³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° ΠΌΠ΅Π»ΡΠ°Π»Π°Π½Π° ΠΈ ΠΎΡΠ΅Π½ΠΊΠ° Π΅Π³ΠΎ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ.Π ΠΎΠ΄Π½ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠΌ ΡΠ°Π½Π΄ΠΎΠΌΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌ Π΄Π²ΠΎΠΉΠ½ΠΎΠΌ ΡΠ»Π΅ΠΏΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ ΡΡΠ°ΡΡΠ²ΠΎΠ²Π°Π»ΠΈ 42 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Ρ ΠΠ ΡΡΠ΅Π΄Π½Π΅ΡΡΠΆΠ΅Π»ΠΎΠΉ ΠΈ ΡΡΠΆΠ΅Π»ΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ. ΠΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ (21 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ) ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΎΡΡ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎΠ΅ ΠΎΠ±ΡΠ΅ΠΏΡΠΈΠ½ΡΡΠΎΠ΅ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ Ρ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΌΠΈ Π΅ΠΆΠ΅Π΄Π½Π΅Π²Π½ΡΠΌΠΈ ΠΈΠ½Π³Π°Π»ΡΡΠΈΡΠΌΠΈ ΠΏΠ»Π°ΡΠ΅Π±ΠΎ. ΠΠ°ΡΠΈΠ΅Π½ΡΠ°ΠΌ ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ (21 ΡΠ΅Π»ΠΎΠ²Π΅ΠΊ), ΠΏΠΎΠΌΠΈΠΌΠΎ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈΡΡ Π΅ΠΆΠ΅Π΄Π½Π΅Π²Π½ΡΠ΅ ΠΈΠ½Π³Π°Π»ΡΡΠΈΠΈ 0,1 ΠΌΠ³ ΠΌΠ΅Π»ΡΠ°Π»Π°Π½Π° Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ 5 Π΄Π½Π΅ΠΉ. ΠΡΠ΅ΠΌ Π±ΠΎΠ»ΡΠ½ΡΠΌ Π΄ΠΎ ΠΈ ΡΠ΅ΡΠ΅Π· 10 Π΄Π½Π΅ΠΉ ΠΏΠΎΡΠ»Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ Π²ΡΠΏΠΎΠ»Π½ΡΠ»ΠΈ ΡΠΏΠΈΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅, Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅, Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π£ 33 ΠΈΠ· 42 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Ρ ΡΠΈΠ±ΡΠΎΠ±ΡΠΎΠ½Ρ
ΠΎΡΠΊΠΎΠΏΠΈΠΈ Ρ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠΈΠΌ Π³ΠΈΡΡΠΎΡΠ»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΠ½ΡΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π±ΡΠΎΠ½Ρ
ΠΎΠ±ΠΈΠΎΠΏΡΠ°ΡΠΎΠ². ΠΠΎΠ±ΠΎΡΠ½ΡΡ
ΡΠ΅Π°ΠΊΡΠΈΠΉ Π½Π° ΠΈΠ½Π³Π°Π»ΡΡΠΈΠΈ ΡΠ»ΡΡΡΠ°Π½ΠΈΠ·ΠΊΠΈΡ
Π΄ΠΎΠ· ΠΌΠ΅Π»ΡΠ°Π»Π°Π½Π° Π½Π΅ Π±ΡΠ»ΠΎ ΠΎΡΠΌΠ΅ΡΠ΅Π½ΠΎ. ΠΠΈ ΠΎΠ΄ΠΈΠ½ ΠΏΠ°ΡΠΈΠ΅Π½Ρ Π½Π΅ Π²ΡΠ±ΡΠ» ΠΈΠ· ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ. Π’ΠΎΠ»Π΅ΡΠ°Π½ΡΠ½ΠΎΡΡΡ ΠΊ ΡΠΈΠ·ΠΈΡΠ΅ΡΠΊΠΎΠΉ Π½Π°Π³ΡΡΠ·ΠΊΠ΅ ΡΠ²Π΅Π»ΠΈΡΠΈΠ»Π°ΡΡ, Π° ΡΠ°ΡΡΠΎΡΠ° ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Ρ2-Π°Π³ΠΎΠ½ΠΈΡΡΠΎΠ² ΠΈ ΡΡΠΆΠ΅ΡΡΡ ΠΏΡΠΈΡΡΡΠΏΠΎΠ² ΠΠ Π² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΡΠ½ΠΈΠ·ΠΈΠ»ΠΈΡΡ (Ρ<0,05). ΠΠΎΠ·ΠΈΡΠΈΠ²Π½ΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ Π²Π½Π΅ΡΠ½Π΅Π³ΠΎ Π΄ΡΡ
Π°Π½ΠΈΡ ΡΠ°ΠΊΠΆΠ΅ Π±ΡΠ»ΠΈ Π±ΠΎΠ»Π΅Π΅ Π²ΡΡΠ°ΠΆΠ΅Π½Ρ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ. ΠΡΠΌΠ΅ΡΠ΅Π½Π° Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½Π°Ρ ΠΏΠΎΠ»ΠΎΠΆΠΈΡΠ΅Π»ΡΠ½Π°Ρ Π΄ΠΈΠ½Π°ΠΌΠΈΠΊΠ° ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ³ΠΎ ΠΈ ΡΠ°Π³ΠΎΡΠΈΡΠ°ΡΠ½ΠΎΠ³ΠΎ Π·Π²Π΅Π½ΡΠ΅Π² ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ, Π² ΡΠΎ Π²ΡΠ΅ΠΌΡ ΠΊΠ°ΠΊ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π°Π½Π°Π»ΠΎΠ³ΠΈΡΠ½ΡΡ
ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΎΠ² Π² ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΠΎΠΉ Π³ΡΡΠΏΠΏΠ΅ Π±ΡΠ»ΠΈ Π½Π΅Π·Π½Π°ΡΠΈΠΌΡ. Π£ 60% ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΎΡΠ½ΠΎΠ²Π½ΠΎΠΉ Π³ΡΡΠΏΠΏΡ ΠΏΠΎΡΠ»Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ ΠΎΡΠΌΠ΅ΡΠ΅Π½Ρ Π³ΠΈΡΡΠΎΡΠ»ΡΡΡΠ°ΡΡΡΡΠΊΡΡΡΠ½ΡΠ΅ ΠΏΡΠΈΠ·Π½Π°ΠΊΠΈ ΡΠ΅Π³Π΅Π½Π΅ΡΠ°ΡΠΈΠΈ ΡΠΏΠΈΡΠ΅Π»ΠΈΡ.ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΠΏΠΎΠΊΠ°Π·Π°Π»ΠΈ, ΡΡΠΎ ΠΈΠ½Π³Π°Π»ΡΡΠΈΠΎΠ½Π½Π°Ρ ΡΠ΅ΡΠ°ΠΏΠΈΡ ΠΠ ΡΠ»ΡΡΡΠ°Π½ΠΈΠ·ΠΊΠΈΠΌΠΈ Π΄ΠΎΠ·Π°ΠΌΠΈ ΠΌΠ΅Π»ΡΠ°Π»Π°Π½Π° ΡΠ²Π»ΡΠ΅ΡΡΡ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΡΠΌ ΠΈ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π»Π΅ΡΠ΅Π½ΠΈΡ Π΄Π°Π½Π½ΠΎΠ³ΠΎ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ; ΡΡΠ΅Π±ΡΡΡΡΡ Π΄Π°Π»ΡΠ½Π΅ΠΉΡΠΈΠ΅ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ Π² ΡΡΠΎΠΌ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½ΠΈΠΈ